Doctoral researcher to Center of Excellence in Tumor Genetics

Academy of Finland’s Center of Excellence in Tumor Genetics / Academy Professor Lauri Aaltonen’s Tumor Genomics research group is looking for an enthusiastic student for a PhD / master’s thesis project, ideally starting in early 2023.

You will play an important part of our world-leading project elucidating the molecular mechanisms behind the genesis of uterine leiomyoma, an extremely common benign tumor of the uterine wall. We are currently setting up various model cell lines to further understand the genetic and epigenetic changes underlying this condition, as well as screening drugs to find novel noninvasive treatment options. The work takes place at the Meilahti campus Helsinki and involves wet-lab experimentation with cultured cells and tissues using various molecular biology methods. The successful applicant is a good team player, has a robust record in previous studies, a bachelor’s degree in a relevant field (genetics/biochemistry/molecular biology), is highly motivated, able to adopt new skills quickly, and is fluent in English. The ability to read pathology reports and similar documents (typically in Finnish) would be a plus. Extensive previous experience in wet-lab work is not obligatory.

We offer a salary based on the applicant’s education and experience; demand level 2 of the teacher-researcher staff according to the salary system of the Finnish universities. The position as a doctoral researcher is at first until 31.12.2025. A 6 month trial period is used.

Alternatively, the position may also be filled as a Master´s thesis-project, with Research assistant as tittle and a 6 month duration. Research assistants are students at the University of Helsinki.

Please send any inquiries regarding the position exclusively to [email protected] Please submit the application by clicking on the Apply link below. The deadline for applications is 27th January 2023.

About us:

Tumor Genomics Group is one of the largest biomedical research groups in Finland with about 30 members, and focuses on human tumor susceptibility as well as somatic cancer genomics. The group is a member of the Academy of Finland’s Center of Excellence in Tumor Genetics Research, and one of few in Europe that has succeeded in winning two consecutive ERC advanced grants.

https://www.helsinki.fi/en/researchgroups/tumor-genomics